Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases

Robert A Casero, Laurence J. Marton

Research output: Contribution to journalArticle

Abstract

The polyamines spermidine and spermine and their diamine precursor putrescine are naturally occurring, polycationic alkylamines that are essential for eukaryotic cell growth. The requirement for and the metabolism of polyamines are frequently dysregulated in cancer and other hyperproliferative diseases, thus making polyamine function and metabolism attractive targets for therapeutic intervention. Recent advances in our understanding of polyamine function, metabolic regulation, and differences between normal cells and tumour cells with respect to polyamine biology, have reinforced the interest in this target-rich pathway for drug development.

Original languageEnglish (US)
Pages (from-to)373-390
Number of pages18
JournalNature Reviews Drug Discovery
Volume6
Issue number5
DOIs
StatePublished - May 2007

Fingerprint

Polyamines
Neoplasms
Diamines
Putrescine
Spermidine
Spermine
Eukaryotic Cells
Growth
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. / Casero, Robert A; Marton, Laurence J.

In: Nature Reviews Drug Discovery, Vol. 6, No. 5, 05.2007, p. 373-390.

Research output: Contribution to journalArticle

@article{a3129f3325d24fbcb4f815850bf24efc,
title = "Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases",
abstract = "The polyamines spermidine and spermine and their diamine precursor putrescine are naturally occurring, polycationic alkylamines that are essential for eukaryotic cell growth. The requirement for and the metabolism of polyamines are frequently dysregulated in cancer and other hyperproliferative diseases, thus making polyamine function and metabolism attractive targets for therapeutic intervention. Recent advances in our understanding of polyamine function, metabolic regulation, and differences between normal cells and tumour cells with respect to polyamine biology, have reinforced the interest in this target-rich pathway for drug development.",
author = "Casero, {Robert A} and Marton, {Laurence J.}",
year = "2007",
month = "5",
doi = "10.1038/nrd2243",
language = "English (US)",
volume = "6",
pages = "373--390",
journal = "Nature Reviews Drug Discovery",
issn = "1474-1776",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases

AU - Casero, Robert A

AU - Marton, Laurence J.

PY - 2007/5

Y1 - 2007/5

N2 - The polyamines spermidine and spermine and their diamine precursor putrescine are naturally occurring, polycationic alkylamines that are essential for eukaryotic cell growth. The requirement for and the metabolism of polyamines are frequently dysregulated in cancer and other hyperproliferative diseases, thus making polyamine function and metabolism attractive targets for therapeutic intervention. Recent advances in our understanding of polyamine function, metabolic regulation, and differences between normal cells and tumour cells with respect to polyamine biology, have reinforced the interest in this target-rich pathway for drug development.

AB - The polyamines spermidine and spermine and their diamine precursor putrescine are naturally occurring, polycationic alkylamines that are essential for eukaryotic cell growth. The requirement for and the metabolism of polyamines are frequently dysregulated in cancer and other hyperproliferative diseases, thus making polyamine function and metabolism attractive targets for therapeutic intervention. Recent advances in our understanding of polyamine function, metabolic regulation, and differences between normal cells and tumour cells with respect to polyamine biology, have reinforced the interest in this target-rich pathway for drug development.

UR - http://www.scopus.com/inward/record.url?scp=34248228763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248228763&partnerID=8YFLogxK

U2 - 10.1038/nrd2243

DO - 10.1038/nrd2243

M3 - Article

VL - 6

SP - 373

EP - 390

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

SN - 1474-1776

IS - 5

ER -